Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010030/S204

LifeVest Wearable Defibrillator

Zoll Manufacturing Corporation · Decision date Oct 5, 2026

FDA DECISIONP010030/S204

What did the FDA decide?

FDA records P010030/S204 as a supplement to PMA P010030, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 5, 2026.

FDA approval order statement

removal of an inspection step performed during manufacturing and servicing
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P010030/S204
Regulatory pathway
PMA supplement
Product code
MVK
Decision code
OK30
Decision date
Oct 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wearable automated external defibrillator.

Product code
MVK
FDA device class
3

For the original device and its historical approval scope, see PMA P010030. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010030 · Original PMA

    WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) 2000 LIFEVEST

  2. P010030/S201 · Related supplement

    LifeVest Wearable Defibrillator

  3. P010030/S204 received

    Application receipt date recorded by FDA.

  4. P010030/S203 · Related supplement

    LifeVest Wearable Defibrillator

  5. P010030/S204 · FDA decision

    30-Day Notice

  6. P010030/S205 · Related supplement

    LifeVest Wearable Defibrillator

Timeline entries are records held by MedtechLedger for P010030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010030

Product / regulatory recordCompanyPathwayDecision dateSource
Zoll Manufacturing CorporationPMA approvalDec 18, 2001FDA
Zoll Manufacturing CorporationPMA supplementSep 9, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 29, 2026FDA
Zoll Manufacturing CorporationPMA supplementOct 6, 2026FDA

Explore the linked device profile

Other records with product code MVK

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zoll Manufacturing Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
121 Gamma Dr., Pittsburgh, PA, 15238

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records